Cannabix Technologies Stock Price To Book

BLOZF Stock  USD 0.27  0.02  6.90%   
Cannabix Technologies fundamentals help investors to digest information that contributes to Cannabix Technologies' financial success or failures. It also enables traders to predict the movement of Cannabix Pink Sheet. The fundamental analysis module provides a way to measure Cannabix Technologies' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cannabix Technologies pink sheet.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Cannabix Technologies Company Price To Book Analysis

Cannabix Technologies' Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.

P/B

 = 

MV Per Share

BV Per Share

More About Price To Book | All Equity Analysis

Current Cannabix Technologies Price To Book

    
  6.90 X  
Most of Cannabix Technologies' fundamental indicators, such as Price To Book, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cannabix Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
Competition

Based on the latest financial disclosure, Cannabix Technologies has a Price To Book of 6.9023 times. This is 73.12% lower than that of the Healthcare sector and 21.73% higher than that of the Medical Devices industry. The price to book for all United States stocks is 27.42% higher than that of the company.

Did you try this?

Run Portfolio Backtesting Now

   

Portfolio Backtesting

Avoid under-diversification and over-optimization by backtesting your portfolios
All  Next Launch Module

Cannabix Fundamentals

About Cannabix Technologies Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Cannabix Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cannabix Technologies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cannabix Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in Cannabix Pink Sheet

Cannabix Technologies financial ratios help investors to determine whether Cannabix Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cannabix with respect to the benefits of owning Cannabix Technologies security.